A tighter archive for life-science signals.
Search once, then narrow by source or topic.
JPM 2026: 10x Genomics Goes Diagnostic, Aims Single-Cell to Clinical Application - Inside Precision Medicine
JPM 2026: 10x Genomics Goes Diagnostic, Aims Single-Cell to Clinical Application - Inside Precision Medicine
Balanced Risk/Reward Keeps 10x Genomics at Hold Despite Solid Execution and Discounted Valuation - TipRanks
Balanced Risk/Reward Keeps 10x Genomics at Hold Despite Solid Execution and Discounted Valuation - TipRanks
10x Genomics (TXG) Sees Modest Q4 Growth Amid Revenue Challenges - GuruFocus
10x Genomics (TXG) Sees Modest Q4 Growth Amid Revenue Challenges - GuruFocus
10x Genomics sees uptick in Q4 revenue despite softer FY sales (TXG:NASDAQ) - Seeking Alpha
10x Genomics sees uptick in Q4 revenue despite softer FY sales (TXG:NASDAQ) - Seeking Alpha
10X Genomics Q4 prelim revenue beats on consumables unit strength - TradingView — Track All Markets
10X Genomics Q4 prelim revenue beats on consumables unit strength - TradingView — Track All Markets
10x Genomics (TXG) Achieves Remarkable Progress Despite Economic Challenges - GuruFocus
10x Genomics (TXG) Achieves Remarkable Progress Despite Economic Challenges - GuruFocus
10x Genomics reports preliminary Q4 revenue $166M, consensus $155.95M - TipRanks
10x Genomics reports preliminary Q4 revenue $166M, consensus $155.95M - TipRanks
10x Genomics Announces Preliminary Select Fourth Quarter and Full Year 2025 Results - PR Newswire
10x Genomics Announces Preliminary Select Fourth Quarter and Full Year 2025 Results - PR Newswire
10X GENOMICS Q4 2025 Earnings Preview: Recent $TXG Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative
10X GENOMICS Q4 2025 Earnings Preview: Recent $TXG Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative
10x Genomics (TXG) Deepens Transplant Research Ties With CareDx, But What Does It Signal Strategically? - simplywall.st
10x Genomics (TXG) Deepens Transplant Research Ties With CareDx, But What Does It Signal Strategically? - simplywall.st
10X Genomics stock hits 52-week high at 20.36 USD By Investing.com - Investing.com Australia
10X Genomics stock hits 52-week high at 20.36 USD By Investing.com - Investing.com Australia
Assessing 10x Genomics (TXG) Valuation After Recent Share Price Momentum Shift - Yahoo Finance
Assessing 10x Genomics (TXG) Valuation After Recent Share Price Momentum Shift - Yahoo Finance
CareDx and 10x Genomics partner on transplant rejection research By Investing.com - Investing.com Nigeria
CareDx and 10x Genomics partner on transplant rejection research By Investing.com - Investing.com Nigeria
A Look At 10x Genomics (TXG) Valuation After The New ImmuneScape Partnership Announcement - simplywall.st
A Look At 10x Genomics (TXG) Valuation After The New ImmuneScape Partnership Announcement - simplywall.st
10x Genomics (TXG) Sees Target Price Increase in Latest Analyst Rating | TXG Stock News - GuruFocus
10x Genomics (TXG) Sees Target Price Increase in Latest Analyst Rating | TXG Stock News - GuruFocus
10x Genomics price target raised to $18 from $15 at TD Cowen - TipRanks
10x Genomics price target raised to $18 from $15 at TD Cowen - TipRanks
Assessing CareDx (CDNA) Valuation After ImmuneScape Multiomics Collaboration With 10x Genomics - simplywall.st
Assessing CareDx (CDNA) Valuation After ImmuneScape Multiomics Collaboration With 10x Genomics - simplywall.st
CareDx and 10x Genomics to Launch ImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response - BioSpace
CareDx and 10x Genomics to Launch ImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response - BioSpace
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page